Page last updated: 2024-10-27

gabexate and Neoplasms

gabexate has been researched along with Neoplasms in 4 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC."9.06Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988)
"The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC."5.06Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988)
"Gabexate Mesilate was thought to be effective and free from complication in case 4, 5."1.28[Report of five cases of major surgery during anticoagulant therapy after prosthetic valve replacement]. ( Abe, T; Hagiwara, K; Hoshino, S; Igari, T; Iwatani, F; Midorikawa, H; Sadogawa, H; Sato, Y; Tanji, M; Watanabe, M, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammendola, M1
Leporini, C1
Marech, I1
Gadaleta, CD1
Scognamillo, G1
Sacco, R1
Sammarco, G1
De Sarro, G1
Russo, E1
Ranieri, G1
Midorikawa, H1
Iwatani, F1
Igari, T1
Abe, T1
Hagiwara, K1
Tanji, M1
Sadogawa, H1
Watanabe, M2
Sato, Y1
Hoshino, S1
Umeki, S1
Adachi, M1
Yaji, S1
Soejima, R1
Wada, H1
Suzuki, H1
Mori, Y1
Deguchi, A1
Oukubo, I1
Tsuda, M1
Tanaka, I1
Deguchi, K1
Shirakawa, S1
Minami, N1

Reviews

1 review available for gabexate and Neoplasms

ArticleYear
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiogenesis Inhibitors; Cell Proliferation; Gabexate; Humans; Inflammation; Mast Cells; Neoplasms;

2014

Trials

1 trial available for gabexate and Neoplasms

ArticleYear
Gabexate as a therapy for disseminated intravascular coagulation.
    Archives of internal medicine, 1988, Volume: 148, Issue:6

    Topics: Anticoagulants; Clinical Trials as Topic; Disseminated Intravascular Coagulation; Gabexate; Guanidin

1988

Other Studies

2 other studies available for gabexate and Neoplasms

ArticleYear
[Report of five cases of major surgery during anticoagulant therapy after prosthetic valve replacement].
    Kyobu geka. The Japanese journal of thoracic surgery, 1990, Volume: 43, Issue:2

    Topics: Adult; Anticoagulants; Dipyridamole; Female; Gabexate; Guanidines; Heart Valve Prosthesis; Heparin;

1990
[Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Nihon Gan Chiryo Gakkai shi, 1988, Jan-20, Volume: 23, Issue:1

    Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Humans; Leuke

1988